A recent study published in the JAMA Surgery claims that surgery may be more effective than lifestyle changes in obese diabetes patients. It seems that people who suffer from type 2 diabetes and have a weight loss surgery, also known as bariatric surgery, may experience more improvements than those who struggle with lifestyle changes.
Type 2 diabetes is the most often met form of diabetes and quite often it is also linked to obesity because the body does not produce enough hormone insulin which enables the cells to use glucose for fuel. Or even though the insulin produced is enough the cells resist them.
The study was conducted on 61 participants with ages between 25 and 55. Half of the participants in the study had class 1 obesity and the other half was heavier than average. Some of the patients underwent weight loss surgery, whereas other underwent intensive lifestyle changes for a year such as behavior exercise, diet and exercise. The first year of intensive intervention was followed by low-intensity interventions which included behavioral counseling a couple of times each month.
Three years after the study began the patients who underwent surgery were in a form of remission in comparison with those who did not have the surgery. The obese patients were chosen randomly for the study and monitored for three years. Some of the participants used either a laparoscopic adjustable gastric banding surgery or a Roux-en-Y gastric bypass.
The Roux-en-Y gastric bypass was more efficient than the laparoscopic adjustable gastric banding surgery. After the period of three years more than two thirds of the participants who used the Roux-en-Y gastric bypass said that they no longer needed diabetes medication, whereas in the case of those who had laparoscopic adjustable gastric banding surgery only one third of them said the same thing.
Overall 40 percent of the participants in the RYBG group, 29 percent of the participants in the LAGB group and 0 percent of the participants in the lifestyle group experienced a partial remission of the disease. Moreover three persons from the RYGB group and one person from the LAGB group were completely freed of this condition.
The lead author of the study, Dr. Anita Courcoulas from the University of Pittsburgh Medical Center said:
“We’ll be able to see what the remissions look like at five and seven years. I think that’s the next step in this field.”
Image Source: YouTube